Use of surrogate endpoints: a practical necessity in lipid-altering and antiatherosclerosis drug development (Q34177780)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Use of surrogate endpoints: a practical necessity in lipid-altering and antiatherosclerosis drug development |
scientific article |
Statements
1 reference
Use of surrogate endpoints: a practical necessity in lipid-altering and antiatherosclerosis drug development (English)
1 reference
Orloff DG
1 reference
1 February 2001
1 reference
1 reference
87
1 reference
4A
1 reference
35A-41A
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference